Suppr超能文献

噬血细胞性淋巴组织细胞增生症危重症患儿:14例病例系列报道

Critically Ill Children With Hemophagocytic Lymphohistiocytosis: A Case Series of 14 Patients.

作者信息

Leow Esther Huimin, Soh Shui Yen, Tan Ah Moy, Mok Yee Hui, Chan Mei Yoke, Lee Jan Hau

机构信息

Departments of *Pediatric Medicine †Hematology/Oncology ‡Children's Intensive Care Unit, KK Women's and Children's Hospital §Duke-NUS School of Medicine, Singapore, Singapore.

出版信息

J Pediatr Hematol Oncol. 2017 Aug;39(6):e303-e306. doi: 10.1097/MPH.0000000000000916.

Abstract

Children with hemophagocytic lymphohistiocytosis (HLH) are at an increased risk of critical illness. In this study, we described the clinical characteristics of critically ill children with HLH and identify factors associated with poor clinical outcomes. Children who were diagnosed with HLH with emergent admission to Children's Intensive Care Unit (CICU) between January 1, 2000 and October 31, 2015 were included. The primary outcome was CICU mortality. Over the 15-year period, there were 14 critically ill patients with HLH with 23 CICU admissions. Median age at HLH diagnosis was 8.2 years (interquartile range [IQR], 2.9 to 11.3). Overall CICU mortality was 8 of 23 CICU admissions (34.8%). Factors that were associated with CICU mortality in critically ill children with HLH identified in this study include: a worse median pediatric index of mortality 2 score (4.7% in survivors [IQR, 2.9% to 11.6%] vs. 2.4% [IQR, 1.2% to 4.3%]; P=0.031); higher median peak serum lactate level (mmol/L) within 24 hours of admission (5.6 [IQR, 2.7 to 17.4] vs. 1.6 [IQR, 1.2 to 2.8]; P=0.032); the need for mechanical ventilation (100% vs. 46.7%; P=0.019); inotropic support (87.5% vs. 20.0%; P=0.006); renal replacement therapy (50% vs. 0%; P=0.008); and blood product transfusion episodes (24.5 [IQR, 14.3 to 46.8] vs. 3.0 [IQR, 1.0 to 9.0]; P=0.002). Further studies are required to validate the factors that are associated with poor outcomes in critically ill children with HLH.

摘要

噬血细胞性淋巴组织细胞增生症(HLH)患儿发生危重症的风险增加。在本研究中,我们描述了危重症HLH患儿的临床特征,并确定了与临床预后不良相关的因素。纳入了2000年1月1日至2015年10月31日期间因HLH紧急入住儿童重症监护病房(CICU)的患儿。主要结局是CICU死亡率。在这15年期间,有14例危重症HLH患儿入住CICU 23次。HLH诊断时的中位年龄为8.2岁(四分位间距[IQR],2.9至11.3岁)。CICU总体死亡率为23次入住中的8例(34.8%)。本研究确定的与危重症HLH患儿CICU死亡率相关的因素包括:较差的中位儿童死亡率指数2评分(幸存者为4.7%[IQR,2.9%至11.6%],而非幸存者为2.4%[IQR,1.2%至4.3%];P=0.031);入院后24小时内较高的中位血清乳酸峰值水平(mmol/L)(5.6[IQR,2.7至17.4],而非幸存者为1.6[IQR,1.2至2.8];P=0.032);需要机械通气(100%,而非幸存者为46.7%;P=0.019);使用血管活性药物支持(分别为87.5%和20.0%;P=0.006);肾脏替代治疗(分别为50%和0%;P=0.008);以及血液制品输注次数(24.5[IQR,14.3至46.8],而非幸存者为3.0[IQR,1.0至9.0];P=0.002)。需要进一步研究以验证与危重症HLH患儿预后不良相关的因素。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验